Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated
Forty Behcet disease patients with pulmonary endoarterectomy will be assigned to group I or Group II. the patients will be adolescents, 20 patients in the group. Group I will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week) Group II will act waitlist group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| group number 1 | Experimental | twenty Behcet disease patients with pulmonary endoarterectomy will be will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week) |
|
| group number 2 | No Intervention | twenty Behcet disease patients with pulmonary endoarterectomy will act as wailisting group for 12 weeks |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| inspiratory muscle trianing | Other | twenty Behcet disease patients with pulmonary endoarterectomy will be will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week) |
| Measure | Description | Time Frame |
|---|---|---|
| forced vital capacity | it si a pulmaonry fucntion test | it will be measured after 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| forced expiratory volume | it will be assessed in first second of expiration | It will be measured after 12 weeks |
| ratio of force vital capcity to first-second-expiratory forced expiration volume |
Not provided
Inclusion Criteria:
Exclusion Criteria:
self-representation of gender identity.
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali MA Ismail, lecturer | Contact | 01005154209 | ali.mohamed@pt.cu.edu.eg | |
| ali mohamed, lecturer | Contact | 01031321109 | fatma1995@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Ali MA Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo University | Recruiting | Giza | Dokki | Egypt |
Not provided
| ID | Term |
|---|---|
| D001528 | Behcet Syndrome |
| ID | Term |
|---|---|
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D014606 | Uveitis, Anterior |
| D015864 | Panuveitis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
it is a pulmoanry fucntion test
| It will be measured after 12 weeks |
| fatigue severity scale | it will assess fatigue perception | It will be measured after 12 weeks |
| child health questainanire parent form assessment of phsyical summary | it is an assessment of quality of life | it will be measured after 12 weeks |
| child health questainanire parent form assessment of mental summary | it is an assessment of quality of life | It will be measured after 12 weeks |
| Ruffier index | it an indiactor for cariorespiratory fitness | It will be measured after 12 weeks |
| maxinmal inspiration pressure | it is an indicator for isnpiratory msucular stength | It will be measured after 12 weeks |
| maxinmal expiration pressure | it is an indicator for expiratory msucular stength | It will be measured after 12 weeks |
| six minute walk test | distance covered during this test will be assessed | It will be measured after 12 weeks |
| D014605 |
| Uveitis |
| D014603 | Uveal Diseases |
| D005128 | Eye Diseases |
| D014657 | Vasculitis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D056660 | Hereditary Autoinflammatory Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D012873 | Skin Diseases, Genetic |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D017445 | Skin Diseases, Vascular |